AdvanDx drums up $8 million
August 18, 2009 by MassDevice staff
Woburn, Mass.-based molecular diagnostics maker raises $8 million in Series C round from existing investors.
AdvanDx drummed up an $8 million Series C funding round from a pair of its existing investors.
The Woburn, Mass.-based molecular diagnostics maker said SLS Venture and LD Pensions ponied up the cash, which the company intends to put toward expanding its product offering and boost its international sales and marketing push.
AdvanDx also said its shareholders elected Tina Christensen, vice president and CFO of Danish health insurance company IHI danmark, to its board of directors.
- Login or register to post comments
-
Printer-friendly version
Permalink
NEWS
BD's profits shrink 10 percent on tax provision
Becton, Dickinson and Company's profits drop 10 percent during the third quarter on a $34...
Medtronic aims to mitigate heart failure woes through the spine
Medtronic Inc. launches a global, randomized clinical trial of spinal cord stimulation as a treatment...
FDA requires nine makers of needleless connectors to conduct post-market surveillance
Baxter, Carefusion and Becton Dickinson among nine companies told by federal regulators to study...
Palomar's losses surge 600 percent
Palomar Medical Technologies Inc. second quarter losses increases 600 percent due to heavy spending...
Zoll posts 285 percent increase in profits during Q3
Chelmsford, Mass-based Zoll Medical Corp. records another strong quarter based on increased sales in...
Top News Stories
SEARCH JOBS
RECENT BLOG POSTS
- Insurers who thought the public plan was a threat have another thing coming
- Now Back to Sales
- Tailoring the message to reach the accountable care organization mandate
- Weekly Wireless Roundup: Psychoanalysis of a nation through Twitter
- Halamka's digest of quality measures for EMR meaningful use
- Seal the deal - or steal it?
- MedGadget's MedTech Monday: Exoskeletons for paraplegics and the battlefield
- How to perform an adhesive lap joint shear strength test: ASTM D1002
- The day before tomorrow
- Now is the time for medical device makers to get on board with accountable care
Navigation
